Phosphoribosyl Pyrophosphate

Phosphoribosyl Pyrophosphate

SCHEMBL9488653

Nc1ccccc1C(=O)O.O=P(O)(O)OC[C@H]1OC(OP(=O)(O)OP(=O)(O)O)[C@H](O)[C@@H]1O

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
P2RY2 P41231 3/20 0.43
P2RY4 P51582 1/20 0.43
FBP1 P09467 1/20 0.42
P2RY14 Q15391 7/20 0.41
B4GALT1 P15291 1/20 0.41
IGF2R P11717 4/20 0.41
SIRT2 Q8IXJ6 1/20 0.41
SIRT1 Q96EB6 1/20 0.41
P2RY6 Q15077 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Anthranilic Acid SCHEMBL16443702 0.88 P2RY2 (0.43) P2RY2P2RY4P2RY14B4GALT1P2RY6
Phosphoribosyl Pyrophosphate SCHEMBL28209513 0.81 FBP1 (0.64) P2RY2P2RY4FBP1P2RY14B4GALT1
Phosphoribosyl Pyrophosphate SCHEMBL21330 0.81 FBP1 (0.64) P2RY2P2RY4FBP1P2RY14B4GALT1
Phosphoribosyl Pyrophosphate SCHEMBL187952 0.81 FBP1 (0.64) P2RY2P2RY4FBP1P2RY14B4GALT1
Phosphoribosyl Pyrophosphate SCHEMBL16018854 0.81 FBP1 (0.64) P2RY2P2RY4FBP1P2RY14B4GALT1
Phosphoribosyl Pyrophosphate SCHEMBL28174133 0.81 FBP1 (0.64) P2RY2P2RY4FBP1P2RY14B4GALT1
SCHEMBL31338633 0.81 FBP1 (0.48) P2RY2FBP1IGF2RSIRT2SIRT1
Phosphoribosyl Pyrophosphate SCHEMBL30360449 0.80 FBP1 (0.62) P2RY2P2RY4FBP1P2RY14B4GALT1
SCHEMBL27336504 0.73 SLC5A1 (0.41) P2RY2P2RY4P2RY14B4GALT1P2RY6
Adenosine Phosphate SCHEMBL5321795 0.72 P2RY1 (0.78) P2RY2FBP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5221736-A Sequential peptide and oligonucleotide syntheses using immunoaffinity techniques BIONEBRASKA, INC. (US) 1993-06-22 US claimed
US-9540652-B2 Metabolic engineering of the shikimate pathway THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-01-10 US disclosed
US-20150044734-A1 METABOLIC ENGINEERING OF THE SHIKIMATE PATHWAY THE REGENTS OF THE UNIVERSITY OF CALIFONIA (US) 2015-02-12 US disclosed
WO-2013033652-A1 METABOLIC ENGINEERING OF THE SHIKIMATE PATHWAY THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2013-03-07 WO disclosed